ATLinsider, if, in fact, NWBO is restricted from posting trial results and TLD because of journal embargoes, then management made a HUGE mistake scheduling today's presentation. The inability to publicly respond to MM's and shorts, gave them the perfect opportunity to drive the price down. The damage has been done but was, in my opinion, completely avoidable with better timing of the release of info.